The National Command and Operation Centre (NCOC) on Tuesday announced that phase III clinical trials for the Covid-19 vaccine will be launched in Pakistan.
The trial is a partnership between the National Institute of Health (NIH) and the CanSinoBio and Beijing Institute of Biotechnology China [BIB].
Earlier in September, China National Biotec Group (CNBG) and Sinovac Biotech Ltd said four more countries have agreed to run late-stage clinical tests of their coronavirus vaccine candidates, as China steps up its efforts in the global race.
Serbia and Pakistan were among the new countries agreeing to Phase 3 trials, as the two companies seek more data overseas amid dwindling new cases in China.
from News Updates From Pakistan - Pakistani News - The Express Tribune https://ift.tt/3006WD0
No comments:
Post a Comment